SCHEMBL9483140

SCHEMBL9483140

CON=C(C(=O)NC1C(=O)N2C(C(=O)OC(c3ccccc3)c3ccccc3)=C(C=P(c3ccccc3)(c3ccccc3)c3ccccc3)CS[C@@H]12)c1csc(NC=O)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1I2 O75469 5/20 0.47
▸ HTR2C P28335 1/20 0.47
▸ PTGS1 P23219 2/20 0.46
▸ PGR P06401 2/20 0.46
▸ PTGS2 P35354 1/20 0.46
▸ ABCB11 O95342 1/20 0.46
▸ PDE4D Q08499 1/20 0.46
▸ MAPT P10636 4/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ USP2 O75604 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ HPGD P15428 1/20 0.46
▸ FAP Q12884 1/20 0.46
▸ ALB P02768 1/20 0.46
▸ PPARG P37231 1/20 0.46
▸ SLC22A6 Q4U2R8 1/20 0.46
▸ SLC22A8 Q8TCC7 1/20 0.46
▸ SLC22A11 Q9NSA0 1/20 0.46
▸ KMT2A Q03164 1/20 0.45
▸ TDP1 Q9NUW8 6/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10530847 0.94 NR1I2 (0.50) NR1I2HTR2CPTGS1PGRPTGS2
SCHEMBL7072611 0.94 NR1I2 (0.50) NR1I2HTR2CPTGS1PGRPTGS2
SCHEMBL9482885 0.92 TDP1 (0.52) NR1I2HTR2CPTGS1PGRPTGS2
SCHEMBL9482880 0.92 TDP1 (0.52) NR1I2HTR2CPTGS1PGRPTGS2
SCHEMBL10810879 0.91 NR1I2 (0.55) NR1I2HTR2CPGRPTGS2MAPT
SCHEMBL10794298 0.91 NR1I2 (0.46) NR1I2HTR2CPTGS1PGRPTGS2
SCHEMBL10530868 0.90 NR1I2 (0.47) NR1I2HTR2CPTGS1PGRPTGS2
SCHEMBL10531302 0.90 NR1I2 (0.47) NR1I2HTR2CPTGS1PGRPTGS2
SCHEMBL10531311 0.90 NR1I2 (0.47) NR1I2HTR2CPTGS1PGRPTGS2
SCHEMBL10530861 0.90 NR1I2 (0.47) NR1I2HTR2CPTGS1PGRPTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0303223-B1 Water-soluble antibiotic composition and water-soluble salts of new cephem compounds FUJISAWA PHARMACEUTICAL CO (JP) 1993-10-20 — — EP disclosed
US-5252731-A Antibiotics FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-10-12 — — US disclosed
US-5110921-A Bactericides FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-05-05 — — US disclosed
US-5104866-A WATER-SOLUBLE ANTIBIOTIC COMPOSITION AND WATER-SOLUBLE SALTS OF CEPHEM COMPOUNDS FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) 1992-04-14 — — US disclosed
US-4960889-A CEPHALOSPORIN INTERMEDIATES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-10-02 — — US disclosed
EP-0103264-B1 NEW CEPHEM COMPOUNDS AND PROCESSES FOR PREPARATION THEREOF FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-12-20 — — EP disclosed
EP-0303223-A2 Water-soluble antibiotic composition and water-soluble salts of new cephem compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1989-02-15 — — EP disclosed
US-4731443-A 7-acylamino-3-vinylcephalosporanic acid derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-03-15 — — US disclosed
EP-0097961-B1 CEPHALOSPORIN DERIVATIVES, A PROCESS FOR THE MANUFACTURE THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES Bristol-Myers Company (US) 1987-11-11 — — EP disclosed
EP-0244637-A1 Starting compounds for 7-acylamino-3-vinylcephalosporanic acid derivatives and processes for their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1987-11-11 — — EP disclosed
US-4507487-A CHEMICAL INTERMEDIATES FOR CEPHALOSPORINS BRISTOL-MYERS COMPANY (US) 1985-03-26 — — US disclosed
US-4500526-A ANTIBIOTICS, BACTERICIDES BRISTOL-MYERS COMPANY (US) 1985-02-19 — — US disclosed
US-4487927-A BACTERICIDES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-12-11 — — US disclosed
US-4486586-A BACTERICIDAL ANTIBIOTICS BRISTOL-MYERS COMPANY (US) 1984-12-04 — — US disclosed
EP-0123024-A2 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-10-31 — — EP disclosed
EP-0103264-A2 New cephem compounds and processes for preparation thereof FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1984-03-21 — — EP disclosed
EP-0097961-A2 Cephalosporin derivatives, a process for the manufacture thereof and pharmaceutical compositions containing said derivatives Bristol-Myers Company (US) 1984-01-11 — — EP disclosed
US-4423213-A ANTIBIOTIC FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1983-12-27 — — US disclosed
US-4409214-A Including cefixime; antibiotics FUJISAWA PHARMACEUTICAL, CO., LTD. (JP) 1983-10-11 — — US disclosed
EP-0030630-A2 7-Acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them; their starting compounds and their preparation FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1981-06-24 — — EP disclosed
Send feedback